Cardioprotective effects of tilianin in rat myocardial ischemia-reperfusion injury

Molecular Medicine Reports

Volumn 11, Issue 3, 2015, Pages 2227-2233

  Guo, Xinhong ^a   Cao, Wenjiang ^a   Yao, Jiaming ^a   Yuan, Yong ^a   Hong, Ye ^a   Wang, Xinchun ^a   Xing, Jianguo ^b  

^a SHIHEZI UNIVERSITY   (China)

^b Xinjiang Institute of Materia Medica   (China)

Author keywords

Apoptosis; Ischemia reperfusion; Myocardial; Tilianin

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCITONIN GENE RELATED PEPTIDE; CASPASE 3; ENDOTHELIN 1; FLAVONOID; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROPRANOLOL; PROSTAGLANDIN F1 ALPHA; PROTECTIVE AGENT; PROTEIN BAX; PROTEIN BCL 2; THROMBOXANE B2; TILIANIN; UNCLASSIFIED DRUG; CARDIOTONIC AGENT; GLYCOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MEGADOSE; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOW DRUG DOSE; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PROSTAGLANDIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; ANIMAL; DISEASE MODEL; DRUG EFFECTS; ENZYME ACTIVATION; GENETICS; METABOLISM; MYOCARDIAL REPERFUSION INJURY; VASCULAR ENDOTHELIUM;

DRACOCEPHALUM; MUS; RATTUS;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CALCIUM-TRANSPORTING ATPASES; CARDIOTONIC AGENTS; CASPASE 3; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; FLAVONOIDS; GLYCOSIDES; MALE; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84916608320     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2954     Document Type: Article

References (33)

1. Kreatsoulas C and Anand SS: The impact of social determinants on cardiovascular disease. Can J Cardiol 26: 8C-13C, 2010.
2. Hausenloy DJ and Yellon DM: New directions for protecting the heart against ischemia-reperfusion injury: targeting the Reperfusion injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 61: 448-460, 2004.
3. Ambrosio G and Tritto I: Reperfusion injury: experimental evidence and clinical implications. Am Heart J 138: S69-S75, 1999.
4. Yellon DM and Baxter GF: Protecting the ischemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality? Heart 83: 381-387, 2000.
5. Li J, Zhang H and Zhang C: Role of inflammation in the regulation of coronary blood flow in ischemia and reperfusion: mechanisms and therapeutic implications. J Mol Cell Cardiol 52: 865-872, 2012.
6. Gottlieb RA: Cell death pathways in acute ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther 16: 233-238, 2011.
7. Koenitze JR and Freeman BA: Redox signaling in inflammation: interactions of endogenous electrophiles and mitochondria in cardiovascular disease. Ann NY Acad Sci 12: 45-52, 2010.
8. Lakshmi SV, Padmaja G, Kuppusamy P and Kutala VK: Oxidative stress in cardiovascular disease. Indian J Biochem Biophys 46: 421-440, 2009.
9. Liou SF, Ke HJ, Hsu JH, et al: San-Huang-Xie-Xin Tang prevents rat hearts from ischemia/reperfusion-induced apoptosis through eNOS and MAPK pathways. Evid Based Complement Alternat 2011: 915051, 2011.
10. Changgen Feng and Qiong Li: The research of Dracocephalum moldavuca L. chemical constituents and pharmacological activities. J Tradit Chin Med 25: 155, 2003.
11. Yong Yuan, JianGuo Xing, YongJun Zhang, et al: Determination the content of tilianin in Dracocephalum moldavuca L. by HPLC. Chin J Exp Tradit Med Formulae 16: 68-69, 2010.
12. Nam KH, Choi JH, Seo YJ, et al: Inhibitory effects of tilianin on the expression of inducible nitric oxide synthase in low density lipoprotein receptor deficiency mice. Exp Mol Med 38: 445-452, 2006.
13. Xinhong Guo, Wenjiang Cao, Xinmei Fan, et al: The protective effects of Tilianin on myocardial ischemia-reperfusion injury in rats. Chin J Exp Tradit Med Formulae 13: 169-172, 2013.
14. Zhao Q, Shao L, Hu X, Wu G, et al: Lipoxin A4 preconditioning and postconditioning protect myocardial ischemia/reperfusion injury in rats. Mediators Inflamm 2013: 231351, 2013.
15. Wei Q, Yin Y, Xi M, et al: Antioxidant properties of magnesium lithospermate B contribute to the cardioprotection against myocardial ischemia/reperfusion injury in vivo and in vitro. J Tradit Chin Med 33: 85-91, 2013.
16. Ahmed LA, Salem HA, Attia AS and Agha AM: Pharmacological preconditioning with nicorandil and pioglitazone attenuates myocardial ischemia/reperfusion injury in rats. Eur J Pharmacol 663: 51-58, 2011.
17. Sun C, Liu C, Li S, et al: Overexpression of GEFT, a Rho family guanine nucleotide exchange factor, predicts poor prognosis in patients with rhabdomyosarcoma. Int J Clin Exp Pathol 7: 1606-1615, 2014.
18. Zhao J, Xue W and Liang S: Protective effects of dracocephalum moldavica extracts on hypoxia/reoxygenation injury of cardiomyocytes in cultured neonatal rat. J Zhenzhou University (Med Sci) 2010: 485-487, 2010.
19. Fan XM, Cao WJ, Xing JG, et al: Study on the protective effect of Dracocephalum total flavones against myocardial ischemia-reperfusion injury in rats. Chin Tradit Patent Med 8: 1625-1629, 2013 (In Chinese).
20. Rajadurai M and Stanely Mainzen Prince P: Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats. Toxicol 230: 178-188, 2007.
21. Tian D, Dmitrieva RI, Doris PA, et al: Protein kinase M zeta regulation of Na/K ATPase: a persistent neuroprotective mechanism of ischemic preconditioning in hippocampal slice cultures. Brain Res 1213: 127-139, 2008.
22. Yorozuya T, Adachi N, Dote K, et al: Enhancement of Na+K+ -ATPase and Ca2+ -ATPase activities in multi-cycle ischemic preconditioning in rabbit hearts. Eur J Cardiothorac Surg 26: 981-987, 2004.
23. Yang G, Fang Z, Liu Y, et al: Protective effects of Chinese traditional medicine Buyang Huanwu decoction on myocardial injury. Evid Based Complement Alternat Med 2011: 930324, 2011.
24. Razavi HM, Hamilton JA and Feng Q: Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol Ther 106: 147-162, 2005.
25. Liu YN, Zhou ZM and Chen P: Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Clin Exp Pharmacol Physiol 35: 211-216, 2008.
26. Benigni A, Perico N and Remuzzi G: Endothelin antagonists and renal protection. J Cardiovasc Pharmacol 35 (4 Suppl 2): S75-S78, 2000.
27. de Hoon JN, Pickkers P, Smits P, et al: Calcitonin gene-related peptide: exploring its vasodilating mechanism of action in humans. Clin Pharmacol Ther 73: 312-321, 2003.
28. Ji L, Fu F, Zhang L, Liu W, Cai X, et al: Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. Am J Physiol Endocrinol Metab 298: E871-E880, 2010.
29. Moudgil R, Menon V, Xu Y, et al: Postischemic apoptosis and functional recovery after angiotensin II type 1 receptor blockade inisolated working rat hearts. J Hypertens 19: 1121-1129, 2001.
30. Chen Z, Chua CC, Ho YS, et al: Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol 280: H2313-H2320, 2001.
31. Kumar D and Jugdutt BI: Apoptosis and oxidants in the heart. J Lab Clin Med 142: 288-297, 2003.
32. Nishihara M, Miura T, Miki T, et al: Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. J Mol Cell Cordial 43: 564-570, 2007.
33. Zhang Q, Xiang J, Wang X, et al: Beta(2)-adrenoceptor agonist clenbuterol reduces infarct size and myocardial apoptosis after myocardial ischaemia/reperfusion in anaesthetized rats. Br J Pharmacol 160: 1561-1572, 2010.